[Complications of transcatheteral occlusion of abdominal arteries (author's transl)].
D000005:Abdomen / Q000098:blood supply; D001158:Arteries; D002015:Bucrylate / Q000009:adverse effects; D002404:Catheterization / Q000009:adverse effects; D003973:Diatrizoate; D004338:Drug Combinations; D004378:Duodenal Diseases / Q000628:therapy; D004621:Embolization, Therapeutic / Q000009:adverse effects*; D005227:Fatty Acids; D005781:Gelatin Sponge, Absorbable / Q000009:adverse effects; D006801:Humans; D007674:Kidney Diseases / Q000628:therapy; D008107:Liver Diseases / Q000628:therapy; D011409:Propylene Glycols; D011506:Proteins / Q000009:adverse effects; D013158:Splenic Diseases; D013272:Stomach Diseases / Q000628:therapy; D015028:Zein
D004338:Drug Combinations; D005227:Fatty Acids; D011409:Propylene Glycols; D011506:Proteins; D003973:Diatrizoate; D002015:Bucrylate; D015028:Zein; C020481:alcoholic prolamine solution
Komplikationen des transkatheteralen Verschlusses von Abdominalaterien.